[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ospedali Riuniti Trieste\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":122},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,72,101],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100586904","evaluating-decision-making-using-chatgpt-4-among-trainees-in-surgery-100586904",false,"NCT06921447","Evaluating Decision-making Using ChatGPT-4 Among Trainees in Surgery","Evaluating ChatGPT-4 as a Decision-Making Support Tool for Surgical Trainees","EDuCATe","Inclusion Criteria:\n\n* Actively enrolled or employed in the general surgery residency or department at the participating institution\n* Willingness to participate and complete all clinical case scenarios\n* Consent to participate in the study\n\nExclusion Criteria:\n\n* Incomplete responses\n* Use of external assistance (e.g., internet search, AI tools) when answering scenarios, as self-reported in instructions","ALL",{"count":19,"type":20},35,"ESTIMATED","OBSERVATIONAL","This study aims to assess whether ChatGPT-4 can support surgical trainees in clinical decision-making. By comparing the performance of ChatGPT-4 with junior residents, senior residents, and attending surgeons on standardized clinical scenarios, the study seeks to understand the potential role of large language models in surgical education. The ultimate goal is to evaluate whether ChatGPT-4 can be safely integrated as a supplementary educational tool to aid junior residents in developing critical thinking and surgical judgment.",[24,25,26],"Artificial Intelligence (AI)","Training","Surgery",[28,29,30,31,32],"artificial intelligence","surgery","training","oncology","emergency","NOT_YET_RECRUITING","2025-04-08",{"date":36,"type":37},"2025-04-10","ACTUAL",{"date":36,"type":20},{"date":40,"type":20},"2025-04-30",{"name":42,"class":43},"Ospedali Riuniti Trieste","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":44},"100536501","comparison-of-nom-for-acld-between-medical-and-surgical-ward-100536501","NCT06265649","Comparison of NOM for ACLD Between Medical and Surgical Ward","Acute Left Colon Diverticulitis: is it Still a Surgical Disease When Only Medical Treatment is Required? A Retrospective Study Based on Propensity Score Matching","Inclusion Criteria:\n\n* patients affected by ALCD using a contrast-enhanced CT scan at admission undergoing NOM\n\nExclusion Criteria:\n\n* immediate indication for surgery (i.e. patients with Hinchey III or IV ALCD or septic patients with Hinchey II)","18 Years",{"count":54,"type":20},175,"In Europe, patients with acute left colon diverticulitis (ALCD) are usually admitted to surgical wards even when only medical treatment is required. The study compares ALCD non-operative management (NOM) between surgical and non-surgical environments regarding clinical outcomes, hospitalization length(LOS), and follow-up.",[57,58,59],"Diverticulitis","Colon Disease","Acute Diverticulitis",[61,62],"diverticulitis","non-operative management","RECRUITING","2025-04-02",{"date":66,"type":37},"2025-04-04",{"date":68,"type":37},"2024-01-01",{"date":70,"type":20},"2026-01",{"name":42,"class":43},{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":17,"minAge":79,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":44},"100575853","palmitoylethanolamide-and-luteolin-in-patients-with-acute-ischemic-stroke-100575853","NCT06777680","Palmitoylethanolamide and Luteolin in Patients with Acute Ischemic Stroke","Efficacy of Palmitoylethanolamide and Luteolin on Early Functional Recovery in Acute Stroke Patients Treated with Thrombectomy: a Pilot Randomized Placebo-controlled Prospective Study","Inclusion Criteria:\n\n* age ≥ 60 years\n* both genders\n* first acute ischemic stroke in the middle cerebral artery area confirmed by angio-CT and CTP, eligible for mechanical thrombectomy according to national guidelines\n* NIHSS \\> 6\n* compliant patients\n* signed informed consent\n\nExclusion Criteria:\n\n* hemorrhagic stroke\n* previous stroke (TIA, ischemic or hemorrhagic stroke)\n* presence of clinically evident neurodegenerative diseases (Alzheimer's disease, Parkinson's disease)\n* presence of psychiatric comorbidity (schizophrenia, bipolar disorder, depressive syndrome)\n* presence of chronic inflammatory diseases (chronic inflammatory bowel disease, vasculitis etc.)\n* current or previous neoplasia\n* uncontrolled diabetes mellitus (glycemia on admission \\>400 mg\u002FdL or \\\u003C50 mg\u002FdL)\n* dysphagia, with inability to feed orally\n* inability to provide informed consent\n* pre-existing disability (pre-stroke mRS \\>2)\n* allergy or hypersensitivity to the study treatment","60 Years",{"count":81,"type":20},60,"INTERVENTIONAL",[84],"NA","Acute ischemic stroke is caused by reduced blood supply to the brain associated with neuroinflammation. This mechanism contributes to acute neuronal death and persists even after reopening of the closed vessel, with consequent limitation of clinical and functional improvement.\n\nExperimental and clinical evidence demonstrated the anti-inflammatory and neuroprotective effect of micronized and ultramicronized Palmitoylethanolamide (PEA).\n\nThe aim of this study is to evaluate the effect of co-ultramicronized PEA and luteolin (700 mg + 70 mg in 10 ml) on the clinical outcomes of patients with acute ischemic stroke undergoing mechanical thrombectomy.",[87],"Acute Ischemic Stroke AIS",[89,90,91,92],"Stroke","Neuroinflammation","Palmitoylethanolamide","Luteolin","2025-01-10",{"date":95,"type":37},"2025-01-16",{"date":97,"type":20},"2025-01",{"date":99,"type":20},"2026-12",{"name":42,"class":43},{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":107,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":17,"minAge":52,"maxAge":4,"enrollmentInfo":109,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":111,"conditions":112,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":118,"completionDateStruct":119,"leadSponsor":121,"locationsCount":5},"100547274","costal-fracture-assessment-for-relief-and-enhancement-of-quality-of-life-100547274","NCT06405841","Costal Fracture Assessment for Relief and Enhancement of Quality of Life","Costal Fracture Assessment for Relief and Enhancement of Quality of Life - CARE Study","CARE","Inclusion Criteria:\n\n* Patients with rib fractures\n\nExclusion Criteria:\n\n* cognitive impairment\n* chronic pain due to pathologic fractures\n* active cancer",{"count":110,"type":20},950,"This study explores the impact of rib fractures on patient well-being and quality of life, aiming to identify effective interventions for pain relief and functional improvement. It investigates the long-term outcomes of conservative treatment for rib fractures, analyzing factors such as analgesic therapy, hospitalization duration, and respiratory infection rates. Anticipated results include a comprehensive assessment of patient quality of life and the potential translational implications for healthcare practice. Furthermore, the study aims to inform healthcare resource optimization, potentially guiding treatment decisions and improving patient outcomes within the National Health Service.",[113,114],"Rib Fractures","Rib Trauma","2024-11-18",{"date":117,"type":37},"2024-11-21",{"date":97,"type":20},{"date":120,"type":20},"2027-01",{"name":42,"class":43},""]